Back
ESC Premium Access

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA-Study)

Session: Poster Session 4 - Pulmonary arterial hypertension - Treatments
Topic: Treatment
Speaker: Associate Professor A. Marra (Naples, IT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Alberto Maria Marra

University of Naples Federico II, Naples (Italy)
0 follower

10 more presentations in this session

Efficacy of the novel thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension

Speaker: Professor T. Kinsella (Dublin, IE)

Access
Abstract
Like
Thumbnail

Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Access
Abstract
Like
Thumbnail

Effects of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension

Speaker: Doctor T. Sasiprapha (Bangkok, TH)

Access
Abstract
Slides
Like
Thumbnail

Electroanatomical mapping of right atrium in patients with pulmonary hypertension

Speaker: Doctor Z. Fingrova (Prague, CZ)

Access
Abstract
Like
Thumbnail

Patient characteristics and treatment patterns in the multicentre, retrospective chart review of first-time Opsumit (macitentan) users in the United States (OrPHeUS)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 4 - Pulmonary arterial hypertension - Treatments

Speakers: Associate Professor A. Marra, Professor T. Kinsella, Professor V. McLaughlin, Doctor T. Sasiprapha, Doctor Z. Fingrova...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources